RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) yesterday and set a price target of ...

Heineken NV (HEIA:NA) (OTC: OTC:HEINY), currently valued at $44.92 billion, received a stock rating upgrade from RBC Capital, moving from 'Underperform' to 'Sector Perform'. The firm also increased ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Humana (HUM – Research Report) yesterday and set a price target of $283.00. The ...

Fintel reports that on February 10, 2025, RBC Capital downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from ...

Coca-Cola's Q4 exceeded expectations amid strong "fundamentals" despite currency headwinds and a market share grab from its ...

RBC Capital lowered the firm’s price target on PepsiCo (PEP) to $164 from $172 and keeps a Sector Perform rating on the ...

In a note to clients, the analysts at RBC Capital Markets argued that an extended period of tariffs could lead to higher ...

RBC Capital raised the firm’s price target on Affirm (AFRM) to $81 from $67 and keeps a Sector Perform rating on the shares. The company delivered a strong quarter with beats across the board and an ...

RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...

CEO Eric Steigerwalt highlighted 2024 as a year of both achievements and challenges. He emphasized the company's progress on strategic initiatives aimed at improving capital efficiency and maintaining ...